These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10704626)
21. [D/D genotype of the gene for angiotensin converting enzyme as a risk factor for post-stent coronary restenosis]. Guarda E; Fajuri A; Marchant E; Martínez A; Jalil J; Illanes G; Vecchiola A; Lazen R; Flores A; Barra V; Irarrázabal S; Ilabaca F Rev Esp Cardiol; 1999 Jul; 52(7):475-80. PubMed ID: 10439670 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for the development of restenosis following stent implantation of venous bypass grafts. Heidland UE; Heintzen MP; Michel CJ; Strauer BE Heart; 2001 Mar; 85(3):312-7. PubMed ID: 11179274 [TBL] [Abstract][Full Text] [Related]
23. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520 [TBL] [Abstract][Full Text] [Related]
24. G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease. von Beckerath N; Schusterschitz Y; Koch W; Griesser K; Mehilli J; Gorchakova O; Schömig A; Kastrati A Atherosclerosis; 2003 Mar; 167(1):135-9. PubMed ID: 12618278 [TBL] [Abstract][Full Text] [Related]
25. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up]. Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207 [TBL] [Abstract][Full Text] [Related]
26. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients. Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937 [TBL] [Abstract][Full Text] [Related]
27. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. Wong SC; Baim DS; Schatz RA; Teirstein PS; King SB; Curry RC; Heuser RR; Ellis SG; Cleman MW; Overlie P J Am Coll Cardiol; 1995 Sep; 26(3):704-12. PubMed ID: 7642863 [TBL] [Abstract][Full Text] [Related]
28. Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. Austrian Wiktor Stent Study Group and European Paragon Stent Investigators. Gyöngyösi M; Yang P; Khorsand A; Glogar D J Am Coll Cardiol; 2000 May; 35(6):1580-9. PubMed ID: 10807464 [TBL] [Abstract][Full Text] [Related]
29. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting. Böttiger C; Koch W; Lahn C; Mehilli J; von Beckerath N; Schömig A; Kastrati A Am Heart J; 2003 Nov; 146(5):855-61. PubMed ID: 14597935 [TBL] [Abstract][Full Text] [Related]
30. Coronary stenting in 1000 consecutive patients. Long-term clinical and angiographic results. Colombo A; Di Mario C; Reimers B; Blengino S; Akiyama T; Ferraro M; Martini G; Di Francesco L; Finci L G Ital Cardiol; 1997 Jan; 27(1):19-31. PubMed ID: 9199940 [TBL] [Abstract][Full Text] [Related]
31. G protein beta3 subunit C825T polymorphism in primary IgA nephropathy. Thibaudin L; Berthoux P; Thibaudin D; Mariat C; Berthoux F Kidney Int; 2004 Jul; 66(1):322-8. PubMed ID: 15200440 [TBL] [Abstract][Full Text] [Related]
32. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Haude M; Erbel R; Issa H; Straub U; Rupprecht HJ; Treese N; Meyer J Am Heart J; 1993 Jul; 126(1):15-22. PubMed ID: 8322658 [TBL] [Abstract][Full Text] [Related]
33. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Cutlip DE; Baim DS; Ho KK; Popma JJ; Lansky AJ; Cohen DJ; Carrozza JP; Chauhan MS; Rodriguez O; Kuntz RE Circulation; 2001 Apr; 103(15):1967-71. PubMed ID: 11306525 [TBL] [Abstract][Full Text] [Related]
34. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene. Koch W; Mehilli J; von Beckerath N; Böttiger C; Schömig A; Kastrati A J Am Coll Cardiol; 2003 Jun; 41(11):1957-61. PubMed ID: 12798565 [TBL] [Abstract][Full Text] [Related]
35. The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis. Ozben B; Diz-Kucukkaya R; Bilge AK; Hancer VS; Oncul A J Thromb Thrombolysis; 2007 Jun; 23(3):181-7. PubMed ID: 17221329 [TBL] [Abstract][Full Text] [Related]
36. Determinants of stent restenosis in chronic coronary occlusions assessed by intracoronary ultrasound. Werner GS; Gastmann O; Ferrari M; Scholz KH; Schünemann S; Figulla HR Am J Cardiol; 1999 Apr; 83(8):1164-9. PubMed ID: 10215277 [TBL] [Abstract][Full Text] [Related]
37. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Hengstenberg C; Schunkert H; Mayer B; Döring A; Löwel H; Hense HW; Fischer M; Riegger GA; Holmer SR Cardiovasc Res; 2001 Mar; 49(4):820-7. PubMed ID: 11230982 [TBL] [Abstract][Full Text] [Related]
38. G protein beta3 subunit gene polymorphism in Turkish hypertensives. Alioğlu E; Ercan E; Tengiz I; Yildiz A; Onsel Türk U; Saygi S; Cam FS; Berdeli A Anadolu Kardiyol Derg; 2008 Oct; 8(5):331-5. PubMed ID: 18849222 [TBL] [Abstract][Full Text] [Related]